Approval · Notice of Compliance 28948 · 2022
APOQUEL: Notice of Compliance 28948
Issued September 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28948
- Date
- September 14, 2022
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form (chewable tablets)
Products in this notice
Medicinal ingredients
- OCLACITINIB MALEATE 3.6 MG per TAB
- OCLACITINIB MALEATE 5.4 MG per TAB
- OCLACITINIB MALEATE 16 MG per TAB